Eisai
4523.T
#1987
Rank
ยฃ6.31 B
Marketcap
ยฃ22.40
Share price
-1.14%
Change (1 day)
-31.78%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): ยฃ1.80

According to Eisai's latest financial reports the company's current EPS (TTM) is ยฃ1.72. In 2022 the company made an earnings per share (EPS) of ยฃ1.26 a decrease over its 2021 EPS that were of ยฃ5.59.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ1.8043.16%
2022ยฃ1.26-77.48%
2021ยฃ5.59-41.88%
2020ยฃ9.62-0.94%
2019ยฃ9.7152.59%
2018ยฃ6.37124.17%
2017ยฃ2.84-49.42%
2016ยฃ5.6137.08%
2015ยฃ4.10-11.75%
2014ยฃ4.64-3.23%
2013ยฃ4.80-18.56%
2012ยฃ5.89-15.51%
2011ยฃ6.97-3.75%
2010ยฃ7.24-1.36%
2009ยฃ7.34